Pipamperone
Template:Short description Template:Cs1 config Script error: No such module "Distinguish". Template:Drugbox
Pipamperone (INN, USAN, BAN), sold under the brand name Dipiperon, is a typical antipsychotic of the butyrophenone family used in the treatment of schizophrenia[1][2] and as a sleep aid for depression.[3] It is or has been marketed under brand names including Dipiperon, Dipiperal, Piperonil, Piperonyl, and Propitan.[2] Pipamperone was discovered at Janssen Pharmaceutica in 1961, and entered clinical trials in the United States in 1963.[4]
Medical uses
Pipamperone was developed for use as an antipsychotic in the treatment of schizophrenia.
Pipamperone might be useful as a hallucinogen antidote or "trip killer" in blocking the effects of serotonergic psychedelics like psilocybin.[5]
Pharmacology
Pipamperone acts as an antagonist of the 5-HT2A,[6] 5-HT2B,[7] 5-HT2C[8] D2,[6] D3,[9] D4,[6][10] α1-adrenergic,[9] and α2-adrenergic receptors.[9] It shows much higher affinity for the 5-HT2A and D4 receptors over the D2 receptor (15-fold in the case of the D4 receptor, and even higher in the case of the 5-HT2A receptor),[6][9][11] being regarded as "highly selective" for the former two sites at low doses.[11][12] Pipamperone has low and likely insignificant affinity for the H1 and mACh receptors, as well as for other serotonin and dopamine receptors.[9]
Pipamperone is considered to have been a forerunner to the atypical antipsychotics, if not an atypical antipsychotic itself, due to its prominent serotonin antagonism.[13][14][15] It is also used to normalise mood and sleep patterns and has antianxiety effects in neurotic patients.[16]
| Site | <templatestyles src="Template:Tooltip/styles.css" />pKiScript error: No such module "Check for unknown parameters". |
|---|---|
| D1 | 5.61 |
| D2 | 6.71 |
| D3 | 6.58 |
| D4 | 7.95 |
| 5 HT1A | 5.46 |
| 5 HT1B | 5.54 |
| 5 HT1D | 6.14 |
| 5 HT1E | 5.44 |
| 5 HT1F | <5 |
| 5-HT2A | 8.19 |
| 5 HT5 | 5.35 |
| 5 HT7 | 6.26 |
| α1 | 7.23 |
| α2A | 6.15 |
| α2B | 7.08 |
| α2C | 6.25 |
Antidepressant effects
Low-dose pipamperone (5 mg twice daily) has been found to accelerate and enhance the antidepressant effect of citalopram (40 mg once daily), in a combination (citalopram/pipamperone) referred to as PipCit (code name PNB-01).[11][18]
See also
References
<templatestyles src="Reflist/styles.css" />
- ↑ Script error: No such module "citation/CS1".
- ↑ a b Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c d Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c d e Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ a b c Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "Citation/CS1".
- ↑ Script error: No such module "citation/CS1".
- ↑ Bart A. Ellenbroek, Alexander R. Cools (eds.) (6 December 2012). Atypical Antipsychotics. Basel: Birkhäuser, pp. 62 f. Template:ISBN.
- ↑ Script error: No such module "Citation/CS1".
Script error: No such module "Check for unknown parameters".
Script error: No such module "Navbox".
Script error: No such module "navboxes". Script error: No such module "Navbox". Script error: No such module "Navbox". Script error: No such module "navbox".Script error: No such module "navboxes".Script error: No such module "Check for unknown parameters".
- Pages with script errors
- Pages with broken file links
- 5-HT2A antagonists
- 5-HT2B antagonists
- 5-HT2C antagonists
- Alpha-1 blockers
- Alpha-2 blockers
- Carboxamides
- Belgian inventions
- Butyrophenone antipsychotics
- D2 antagonists
- D3 antagonists
- D4 antagonists
- Janssen Pharmaceutica
- 4-Fluorophenyl compounds
- Piperidines
- Typical antipsychotics